tiprankstipranks
Trending News
More News >
NFL Biosciences SA (DE:82F)
FRANKFURT:82F
Germany Market

NFL Biosciences SA (82F) Financial Statements

Compare
1 Followers

NFL Biosciences SA Financial Overview

NFL Biosciences SA's market cap is currently €18.24M. The company's EPS TTM is €-0.142; its P/E ratio is -4.95; NFL Biosciences SA is scheduled to report earnings on October 16, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 46.00€ 200.01K€ 0.00€ 39.00€ 3.00
Gross Profit€ -67.14K€ -56.06K€ -2.24M€ -530.73K€ -169.36K
Operating Income€ -2.79M€ -4.43M€ -3.01M€ -901.87K€ -318.03K
EBITDA€ -2.65M€ -4.05M€ -2.81M€ -1.08M€ -271.09K
Net Income€ -2.08M€ -3.75M€ -2.44M€ -978.24K€ -266.49K
Balance Sheet
Cash & Short-Term Investments€ 2.11M€ 2.53M€ 1.21M€ 3.20M€ 310.20K
Total Assets€ 3.61M€ 3.97M€ 2.40M€ 3.69M€ 576.64K
Total Debt€ 40.98K€ 62.17K€ 83.26K€ 85.01K€ 85.00K
Net Debt€ -1.87M€ -2.28M€ -970.33K€ -2.95M€ -225.20K
Total Liabilities€ 2.63M€ 3.62M€ 1.55M€ 397.73K€ 426.61K
Stockholders' Equity€ 976.43K€ 349.94K€ 844.00K€ 3.29M€ 150.03K
Cash Flow
Free Cash Flow€ 0.00€ 0.00€ 104.89K€ 87.00K€ 83.91K
Operating Cash Flow€ 0.00€ 0.00€ 104.89K€ 87.00K€ 83.91K
Investing Cash Flow€ 0.00€ 0.00€ 0.00€ 0.00€ 0.00
Financing Cash Flow€ 0.00€ 0.00€ 0.00€ 0.00€ 0.00
Currency in EUR

NFL Biosciences SA Earnings and Revenue History

NFL Biosciences SA Debt to Assets

NFL Biosciences SA Cash Flow

NFL Biosciences SA Forecast EPS vs Actual EPS